Clinical Trials Directory

Trials / Terminated

TerminatedNCT01140295

Bowel Preparation for Colonoscopy in Children

Polyethylene Glycol Powder Solution vs Senna for Bowel Preparation for Colonoscopy in Children: A Prospective, Randomized, Investigator-Blinded Trial.

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Children's Hospital of Philadelphia · Academic / Other
Sex
All
Age
6 Years – 21 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to determine whether Miralax results in a more efficacious preparation as compared to senna for pediatric colonoscopy.

Detailed description

Study subjects will be randomized in two groups: Group one will receive 1.5 g/kg of Miralax orally the day before procedure and one day of clear liquid diet, while subjects in Group 2 will receive two doses of senna the day before procedure with two days of liquid diet (one day full liquid and one day clear liquid diet). On the day of the procedure parents/subjects will complete a questionnaire regarding prep compliance and adverse events. Electrolytes will be obtained prior to colonoscopy to monitor for electrolyte imbalance. Endoscopists will assess preparation for colonoscopy using validated cleanliness scale (Aronchick scale).

Conditions

Interventions

TypeNameDescription
DRUGpolyethylene glycol, sennaSenna dosage: Age 6-12 years: 3 teaspoons or 3 tablets by mouth 2 nights before endoscopy and 1 night before endoscopy. Age \>12 years: 6 teaspoons or 6 tablets by mouth 2 nights before endoscopy and 1 night before endoscopy. A Fleet's rectal enema is administered on the morning of the procedure. Miralax at a dose of 1.5 grams/kg divided twice a day for two days; maximum of 51 grams per dose. Dissolve each 17 grams (1 capful) PEG-P in 240 mL water or other beverage according to the manufacturer's direction and to give the appropriate amount of PEG solution twice a day for two days.

Timeline

Start date
2010-09-01
Primary completion
2011-05-01
Completion
2011-05-01
First posted
2010-06-09
Last updated
2013-04-12
Results posted
2013-04-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01140295. Inclusion in this directory is not an endorsement.